top border
top border
Featured Programs

New Agents in Chronic Lymphocytic Leukemia: A Practical Guide
This expert panel discussion led by William Wierda, MD, focuses on new agents available for the treatment of chronic lymphocytic leukemia.

Dr Wierda is joined in this discussion by Alessandro Ferrajoli, MD; Richard R. Furman, MD; Thomas J. Kipps, MD, PhD; Shuo Ma, MD, PhD; and Susan M. O'Brien, MD. The panelists share their experiences in treating patients with CLL, including prognostic factors, use of chemoimmunotherapy, and the potential for newer agents that are now available or being studied.

View Now

Initiating Therapy for Chronic Lymphocytic Leukemia
In this segment William Wierda, MD, PhD, and Jennifer Brown, MD, PhD, discuss the triggers for starting therapy in a patient who has chronic lymphocytic leukemia.

View Now

Featured Video

Hepatocellular Carcinoma (HCC):
Can We Improve Patient Survival?

Hepatocellular Carcinoma (HCC): Can We Improve Patient Survival?
Richard Finn, MD, Laura M. Kulik, MD, and Matthew S. Johnson, MD, FSIR, discuss the evolving systemic treatment paradigm for patients with advanced hepatocellular carcinoma. View now

Gina Columbus

Gina Columbus reports on the latest news in oncology in this week's edition of OncLive News Network.

Publication Bottom Border
Border Publication